Visual Pathway Neoplasm — Trials

Visual Pathway Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01089101	Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma	active not recruiting	Phase 1 / Phase 2	217	National Cancer Institute (NCI)NIH	1	Sep 21, 2026	clinicaltrials
NCT01837862	A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas	active not recruiting	Phase 1 / Phase 2	10	Julie KrystalOTHER	1	Aug 6, 2026	clinicaltrials
NCT00638898	Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor	completed	Phase 1	25	City of Hope Medical CenterOTHER	1	Mar 20, 2025	clinicaltrials
NCT03326388	Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours

Data updated 4 days agoSource updated Sep 21, 2026source: clinicaltrials